Trial Profile
Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Fludarabine (Primary) ; Rituximab (Primary)
- Indications Chronic lymphocytic leukaemia; Lymphoma
- Focus Pharmacogenomic; Therapeutic Use
- 16 Nov 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 16 Nov 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 16 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.